To understand disease mechanisms, a large-scale analysis of human-yeast genetic 
Introduction
studies of human-yeast genetic interactions have been performed using an array format, which is laborious and time-consuming. Efficient methods for genome-wide screens of human-yeast genetic interactions are needed.
ALS, also known as Lou Gehrig's disease, is a neurodegenerative disease involving motoneuron loss in the cerebral cortex, brainstem, and spinal cord (Cleveland and Rothstein 2001; Ferraiuolo et al. 2011) . Riluzole is the only drug that has been approved by the US Food and Drug Administration for ALS therapy; several therapeutic agents are in clinical trials (Sreedharan and Brown 2013) . Mutations in several genes, including
SOD1, TARDBP, FUS RNA binding protein (FUS), valosin-containing protein (VCP),
FIG4 phosphoinositide 5-phosphatase (FIG4), optineurin (OPTN), angiogenin (ANG), and ubiquilin 2 (UBQLN2), are associated with familial and sporadic ALS (Greenway et al. 2006; Van Damme and Robberecht 2009; Maruyama et al. 2010; Ticozzi et al. 2011) .
OPTN is an adaptor protein that interacts with RAB8 (del Toro et al. 2009 ), huntingtin (Anborgh et al. 2005; del Toro et al. 2009 ), myosin VI (Sahlender et al. 2005) , TANKbinding kinase 1 (Gleason et al. 2011) , and transferrin receptor (Nagabhushana et al. 2010) . OPTN has been implicated in membrane trafficking (Sahlender et al. 2005; Au et al. 2007; Nagabhushana et al. 2010 ) and signaling to induce NF-κB activation (Zhu et al. 2007 ; Nagabhushana et al. 2011 ). Overexpression of wild-type and mutant OPTN induces the death of ocular cell types (Park et al. 2006; Shen et al. 2011) . OPTN is also an autophagy receptor that mediates the clearance of cytosolic Salmonella (Wild et al. 2011) .
ANG, another ALS-linked gene, plays roles in tumor angiogenesis (Pavlov and Badet 2001; Kishimoto et al. 2005) , processing of ribosomal RNA , and neuroprotection (Kieran et al. 2008; Sebastia et al. 2009 ). Recent studies have indicated that ANG is a stress-activated RNase. ANG-cleaved tRNA fragments inhibit translation initiation and promote stress granule assembly (Emara et al. 2010; Ivanov et al. 2011; Skorupa et al. 2012) . Wild-type ANG reduces the death of motoneurons in an ALS mouse model (Kieran et al. 2008 ), while mutant ANG or knockdown of ANG promotes hypoxiainduced cell death (Kieran et al. 2008; Subramanian et al. 2008; Sebastia et al. 2009 ). In addition, ANG plays a protective role in a mouse model of Parkinson's disease (Steidinger et al. 2011) . Despite recent progress in the field, the molecular and cellular bases for neurodegeneration in ALS are not yet established. Understanding how ALSCold Spring Harbor Laboratory Press on July 11, 2017 -Published by genome.cshlp.org Downloaded from linked genes modulate motoneuron degeneration is a key for understanding ALS pathology and protecting motoneurons from damage during disease progression. Here, to better understand disease pathways, we performed a human-yeast genetic interaction screen for human disease genes in a pool format. Subsequent studies focused on ALSassociated genes (OPTN and ANG) and their toxicity modifiers.
Results

Selection of OMIM genes that induce strong toxicity in yeast
OMIM is a compendium of human genes and genetic phenotypes for all known Mendelian disorders. OMIM focuses on the relationship between phenotype and genotype. However, disease mechanisms are not clearly understood for most human disease genes. Gene or protein interaction networks for the disease genes may improve understanding of disease mechanisms Vidal et al. 2011 ). The S. cerevisiae genome has been sequenced in its entirety (Goffeau et al. 1996) , and genetic interactions have been profiled for ~75% of the genes (Costanzo et al. 2010 ). This knowledge base can be used for functional analysis. In our high-throughput, toxicitybased screens of genetic interactions between human disease genes and yeast genes, the toxicity of human OMIM genes was first evaluated in yeast. OMIM ORFs were cloned into pAG425Gal-ccdB under the control of the GAL1 promoter to enable inducible overexpression in yeast. We selected a set of 1,305 genes associated with human disorders in OMIM from human ORFeome collections (ORFeome 1.1 (Rual et al. 2004 ); ORFeome 3.1 (Lamesch et al. 2007 ); ORFeome 7.1, http://horfdb.dfci.harvard.edu/hv7).
Spotting assays on SGal-Leu agar plates were performed to determine the toxicity of OMIM ORFs in yeast. Of 1,305 human OMIM genes tested, 20 OMIM ORFs induced strong toxicity when expressed in yeast (Fig. 1A) . Among the 20 OMIM ORFs, yeast toxicity of OPTN was consistent with a previous report (Kryndushkin et al. 2012 ).
Unfortunately, several human disease genes known to be toxic in yeast, e.g. TARDBP, FUS, HNRNPA1 etc, were not included in the initial human ORFeome collections that we used for screen. The 20 OMIM ORFs that were highly toxic in yeast were subjected to
Cold Spring Harbor Laboratory Press on July 11, 2017 -Published by genome.cshlp.org Downloaded from further study; OMIM ORFs with modest toxicity were excluded. The DNA sequences of expression clones for the 20 OMIM ORFs were verified by Sanger sequencing. Because several human proteins associated with neurodegenerative diseases, such as synuclein alpha and TARDBP, were found to form cytoplasmic aggregates in yeast in previous studies (Gitler 2008; Johnson et al. 2008) , we hypothesized that the toxicity of the 20 human genes was linked to the formation of protein aggregates in yeast. To test this hypothesis, the 20 human genes were expressed in yeast as GFP-fused proteins, which were then visualized under a fluorescence microscope. Of the 20 human genes, 16 genes induced the formation of protein aggregates when expressed in yeast. Protein aggregation was not observed for four genes: sodium channel epithelial 1 beta subunit; bone morphogenetic protein 1; complement factor H; and lysozyme (Fig. 1B) . Interestingly, most of the OMIM genes tested, regardless of their previous association with neurodegenerative disease, formed toxic aggregates. These characteristics can be used for high-throughput genetic or chemical screens of toxicity modifiers. The 20 OMIM genes that induced toxicity in yeast are listed with their predicted disease phenotypes in Table 1 .
The formation of GFP-fused protein foci, however, might not necessarily indicate aggregation and might indicate subcellular localization, such as organelle, vesicle, or nonmembrane bound compartment. Nevertheless, a strong toxicity of the human genes in yeast precluded further characterization of the aggregation via a biochemical technique.
Identification of human-yeast genetic interactions using a genome-wide pooled screen in yeast
To identify human-yeast genetic interactions for the 20 toxic OMIM genes, we performed a genome-wide pooled screen, in which genetic interactions were identified from toxicity modification in a pooled and multiplexed format (Fig. 2) abundance indicates the differential growth of a deletion strain, which reflects the modulation of OMIM gene toxicity in the absence of a specific yeast gene (Smith et al. 2009; Smith et al. 2010) .
Using this method, we obtained a list of OMIM-yeast genetic interactions for the 20 OMIM genes (Supplemental Table S1 ). The toxicity modifier list was obtained using the normalized Bar-seq data. Toxicity suppressors and enhancers were identified from the corrected Z-score, and the toxicity modifiers were divided into three groups: toxicity suppressors, Z-score > 1.96; toxicity enhancers, Z-score < -1.96; and no-effect, yeast deletions that were not suppressors or enhancers (Supplemental Table S2 ). Suppression or enhancement of OMIM toxicity by deletion of a specific yeast gene was tested using individual yeast deletion strains in order to validate the results of the large-scale OMIMyeast genetic interaction screen. Several toxicity modifiers were selected from each group in the OPTN modifier list. Modification of OPTN toxicity was tested in the selected yeast deletion strains. When OPTN was individually expressed in the selected deletion strains, the results of the spot assay and the genome-wide screen were consistent for 75% of the genes in the suppressor group and 62.5% of those in the no-effect group. However, consistency between the pooled assay and spot assay was low for the enhancer list (12.5%). Representative images of the OPTN spot assay are shown in Fig. 3 . The galactose-induced toxicity of OPTN was modified in specific yeast deletion strains. The toxicity and protein aggregation patterns of GFP-tagged OPTN proteins and untagged proteins were similar when assessed in several yeast deletion strains (Supplemental Fig.   S1 ). A similar validation experiment was conducted for the small number of CLINT1 modifiers (consistency for the suppressor list = 62.5%; no-effect group = 62.5%; enhancer list = 25%). The validation experiment was further extended to 10% of randomly selected modifying genes from toxicity suppressors and enhancers for the three OMIM genes (OPTN, ANG, and CLINT1) (Supplemental Table S3 , Supplemental Fig.   S2 ). In the large-scale validation experiments, average consistency for the three OMIM genes was increased from 68.7% to 77.9% for toxicity suppressors. High inconsistencies were still observed for toxicity enhancers (average consistency 24.4%). Thus, the validity of the genome-wide genetic interaction screen using toxicity modification and Bar-seq appeared to be limited to toxicity suppressors, possibly because query gene-induced toxicity was too strong to detect toxicity enhancers. Therefore, OMIM-yeast genetic interactions were defined by the detection of yeast gene deletions suppressing the yeast toxicity of a given human OMIM ORF.
To identify OMIM-human gene interactions, human orthologs of the yeast toxicity suppressors were found using the Karolinska Institute's InParanoid Database (http://inparanoid.sbc.su.se) and NCBI's HomoloGene (http://www.ncbi.nlm.nih.gov/homologene) (Supplemental Table S4 ). An OMIM-human gene interaction network was constructed using the human orthologs of yeast toxicity suppressors for the 20 OMIM genes (Fig. 4) . This network also revealed the relationships among the 20 OMIM genes. IPA-based protein-protein interactions were also included in the network. Thus, a genome-wide human-yeast genetic interaction screen followed by a search for human orthologs provided a 'first draft' disease-gene interaction network for a subset of human disease genes. (Table 2) . Interestingly, the list of human orthologs included other OMIM genes, indicating a functional connection between the ALS-associated genes and other OMIM genes. This was also evident in the subnetwork that focused on OPTN and ANG (Supplemental Fig. S3 ). Next, we used individual yeast deletion strains to test the genetic interactions between the ALS-associated OMIM genes (OPTN and ANG) and yeast genes whose human orthologs were enriched for different biological functions (Table 2 ). The formation of protein aggregates was examined in yeast deletion strains overexpressing OPTN or ANG. Deletion of specific yeast genes attenuated the formation of OPTN or ANG protein aggregates (Fig. 5A) . The yeast deletions, their human orthologs, and the functional categories are listed in Table 3 . We found that deletion of four yeast genes (CKB2, YAP1801, MDE1, and MKK1) attenuated the formation of both OPTN and ANG protein aggregates (Fig. 5B) , indicating cross-interaction between OPTN/ANG and the four yeast genes. Although MKK1 deletion completely reversed the OPTN protein aggregation, the effect of MKK1 deletion on the ANG protein aggregate was modest; it partly attenuated the ANG protein aggregation. Genetic interaction of ANG was further validated using yeast spotting assay (Supplemental Fig. S4 ). From these results, we constructed a predicted network of OPTN/ANG-human genetic interactions (Fig. 5C ). The predicted network also included protein-protein interactions, transcriptional regulation, and phosphorylation. The two ALS-associated genes, OPTN and ANG, shared many genetic and protein interaction partners.
Genetic interactions between ALS-associated genes and yeast toxicity modifiers
Genetic interaction of ALS-associated genes in mammalian cells
Genetic interactions between the ALS-associated genes and the human orthologs of the yeast toxicity modifiers were investigated in mammalian cells in culture. The studies in mammalian cells focused on MAP2K5 (human ortholog of yeast MKK1, a common genetic interaction partner for OPTN and ANG), for which a pharmacological inhibitor is commercially available. Because kinases are one of the most exploited therapeutic targets in the current pharmacological research, we focused on MAP2K5 kinase in the subsequent study. Formation of protein aggregates was first examined after transfection with either wild-type or disease-linked variants of OPTN and ANG (Fig. 6 ).
Two OPTN mutants and three ANG mutants were used: OPTN E50K, found in glaucoma patients (Rezaie et al. 2002) ; OPTN E478G (Maruyama et al. 2010 and their genetic interaction with MKK1 deletion was not as strong as that of WT.
Genetic interactions of ALS-associated genes in zebrafish
We used a zebrafish model to evaluate the genetic interaction between the ALSassociated genes and MAP2K5. Zebrafish is considered as an excellent vertebrate model for the molecular and genetic dissection of motor neuron disease mechanisms (Babin et al. 2014 ). In many neurodegenerative diseases, both "gain of function" and "loss of function" previous study using TARDBP Q331K mutant model of ALS (Paik et al. 2015) .
Altogether, these data indicate that overexpression of mutant variants of ANG and OPTN causes motor axonopathy.
The disease modifying function of MAP2K5 was next tested using an antisense morpholino oligonucleotide against map2k5 (map2k5 MO), which inhibits map2k5 expression by blocking its translation (Fig. 8 ). The specificity of the map2k5 MO was confirmed by injecting it into zebrafish embryos with a cmv:map2k5-efgp construct, which expressed EGFP-tagged MAP2K5 under the control of the cmv promoter. The embryos injected with map2k5 MO and the cmv:map2k5-egfp construct showed a very low level of EGFP expression (Fig. 8B) , whereas the embryos injected with a scrambled MO and cmv:map2k5-egfp exhibited strong EGFP expression (Fig. 8A) , demonstrating that the map2k5 MO inhibited map2k5-egfp expression. To further quantify the level of morpholino-induced MAP2K5 knockdown, we used another ectopic MAP2K5 expression system, because there is no antibody available to detect endogenous MAP2K5 protein in zebrafish (Supplemental Fig. S10 ). We first generated hsp70:map2k5-mCherry DNA construct which expresses MAP2K5-mCherry fusion protein under the control of heatshock inducible promoter (hsp70). Next, hsp70:map2k5-mCherry DNA was injected into the one cell stage zebrafish embryos together with either control MO or MAP2K5 MO. the fusion of autophagosomes and lysosomes as described previously (Klionsky et al. 2012; Nyfeler et al. 2012 ). These results suggest that MAP2K5 knockdown in zebrafish augments the autophagy process to alleviate motoneuron damage. Deletion of MAP2K5 (MKK1) also enhanced autophagy in yeast (Supplemental Fig. S15 ), indicating that MAP2K5 regulates autophagy in both mammalian cells and yeast. The results also led us to speculate that knockdown or deletion of MAP2K5 exerts protective effects against the ANG and OPTN toxicity in zebrafish and yeast via similar mechanisms.
Discussion
To enhance our understanding of disease pathways, a large-scale human-yeast genetic interaction screen was performed. Of 1,305 human disease genes in the OMIM database, 20 genes were highly toxic when overexpressed in yeast (Fig. 1A , Table 1 ).
OMIM gene-induced yeast toxicity formed the phenotypic basis for a genome-wide screen of human-yeast genetic interaction (Fig. 2) . En masse transformation of the toxic OMIM genes into a barcoded yeast deletion library and subsequent multiplexed barcode sequencing identified OMIM-yeast genetic interactions. Genetic interactions between human disease genes and yeast genes has been investigated previously (Giorgini et al. 2005; Cooper et al. 2006; Gitler 2008) . However, in the previous studies, a single human gene was introduced into each yeast deletion strain in an array format. Compared with the method used in the previous studies, our method is faster and more cost effective; it identified genome-wide human-yeast genetic interactions for 20 OMIM genes at the same time in a pooled and multiplexed format. However, our method has a few drawbacks.
Because genetic interaction in the current method is based solely on the suppression of OMIM gene toxicity in yeast deletion strains, disease genes that are not toxic in yeast under any growth conditions will not be suitable for this screen. Although this method did not efficiently identify genetic interactions that enhanced OMIM toxicity, we expect that it could be achieved by variants of the approach described here (e.g., by using a lower expression level of the human gene to reduce baseline toxicity or via deeper barcode sequencing at earlier time points to more quantitatively detect under-representation of specific deletion strains). It should also be noted that the toxicity phenotype was used as a starting point to analyze genetic interactions allowing us to know more about the biology 1 4 of these proteins. Overexpression in yeast might not be the best approach, since the disease mechanisms might be related to loss of function for recessive mutations.
OMIM gene toxicity has been linked to the formation of protein aggregates in yeast.
This feature was used to analyze the genetic interactions of the ALS-associated genes.
Genes involved in neurodegenerative diseases often form protein aggregates when expressed in yeast, leading to cellular toxicity (Giorgini et al. 2005; Cooper et al. 2006; Johnson et al. 2008 ). Of the 20 OMIM genes screened, OPTN and ANG, which have been linked to ALS in previous reports, were the focus of further studies. In this study, OPTN and ANG overexpression similarly induced a protein aggregation phenotype (Fig. 1B) .
Consistently, OPTN has been shown to form toxic aggregates in yeast (Kryndushkin et al. 2012 ). Our results showed that cytoplasmic aggregates of OPTN and ANG were reduced MAP2K5/MAPK7 pathways have been implicated in diverse cellular processes such as cell survival, apoptosis, motility, differentiation, and proliferation (Drew et al. 2012 ).
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Because of the involvement of MAP2K5/MAPK7 in angiogenesis, the epithelialmesenchymal transition, and diverse oncogenic pathways, the role of MAP2K5/MAPK7 in cancer has been the subject of intense investigation for the last decade (Lochhead et al. 2012 ). In the nervous system, MAP2K/MAPK pathways are associated with neuronal cell death (Subramaniam et al. 2004; Subramaniam and Unsicker 2010) and survival (Wang et al. 2005; Cavanaugh et al. 2006; Parmar et al. 2014) , as well as with neuropathic pain (Ma and Quirion 2005) . In particular, MAPK7 has been implicated in neuronal survival and death (Cavanaugh 2004; Subramaniam et al. 2004 ). Overexpression of MAPK7 has been shown to promote apoptotic cell death in medulloblastoma cell lines (Sturla et al. 2005 ). MAPK7 suppresses brain-derived neurotrophic factor (BDNF) expression in the glial cells (Su et al. 2011) . MAPK7 also plays a critical role in the BDNF-promoted survival of developing, but not mature, cortical neurons (Liu et al. 2003) . How 
Materials and Methods
Yeast strains, media, and plasmids BY4742 (Mat α; his3Δ1; leu2Δ0, lys2Δ0; ura3Δ0) was used as a wild-type yeast strain in destination vectors. Human OPTN or ANG variants were generated with the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA), as described in the manual, using specific oligonucleotides.
Yeast transformation and spotting assays
OMIM ORFs in pAG425GAL (yeast destination vector) were transformed into BY4742 or homozygous diploid deletion strains. All yeast strains were grown at 30°C according to the standard protocol. We used the LiAc/SS carrier DNA/PEG method to transform yeast with plasmid DNA as previously described (Gietz and Schiestl 2007) . For spotting assays, yeast cells were grown overnight at 30°C in SRaf-Leu media. Cultures were serially diluted and spotted onto SD-Leu or SGal-Leu medium and grown at 30°C for 2-4 days.
Human-yeast genetic interaction screen
OMIM ORFs were transformed into homozygous diploid yeast deletion pools containing then incubated in SGal-Leu medium for 2 days. Genomic DNA was isolated from cells harvested at the end of pooled growth. Each 20-mer uptag barcode was amplified using composite primers comprised of the sequences of the indexing tag and the sequences of the common barcode primers: 5′-GNNNNNNGATGTCCACGAGGTCTCT-3′ (forward) and 5′-CNNNNNNGTCGACCTGCAGCGTACG-3′ (reverse). The 5′ portion (italics) is the variable sequence, which represents the 6-mer indexing tag used for multiplexing.
The 3′ portion (bold) represents the common primer flanking the uptag barcode; it is required to amplify the yeast barcodes. PCR amplification was carried out at an annealing temperature of 55°C for 30 cycles using a DNA Engine Tetrad Peltier Thermal Cycler (MJ Research, Waltham, MA). The PCR products were gel-purified from 4% agarose gels.
Equal volumes of normalized DNA were then pooled in one tube and sequenced using a Genome Analyzer (Illumina, San Diego, CA) according to the manufacturer's protocols.
Analysis of Illumina sequencing
To analyze the barcode sequencing (Bar-seq) data, all counts were quantile normalized such that each barcode number was divided by the average of the barcode numbers. This ensured that each OMIM experiment had the same count distribution. The normalized barcode number was converted into a Z-score for each yeast gene. The error rate for the Z-score was also calculated by error propagation starting from the estimated error rate of the barcode number. The corrected Z-score was calculated using the error rate as follows:
corrected Z-score = (1 ± error rate) × Z-score.
Bioinformatic analysis and network construction
IPA and DAVID (http://david.abcc.ncifcrf.gov/) were used to construct networks of protein-protein interaction, transcriptional regulation, phosphorylation, subcellular localization, and molecular function. Cocktail (Roche). After centrifugation for 10 min at 12,000 rpm, the supernatant, which constituted the soluble fraction, was collected. The pellet was resuspended in NP40 buffer containing 2% SDS to yield the insoluble fraction. The soluble and insoluble fractions were analyzed with SDS-PAGE followed by western blot detection of GFP-fused proteins using an anti-GFP antibody (Santa Cruz Biotechnology, Santa Cruz, CA; sc-9996). For some experiments, NIH3T3 cells were transfected with the mCherry-GFP-LC3 plasmid to monitor autophagy flux, as described previously (Klionsky et al. 2012; Nyfeler et al. 2012 ). Samples were collected and subjected to immunoblot analysis using antibodies against ATG8 (Abcam; ab4753). Separation of ATG8 from ATG8-PE (phosphatidylethanolamine) was done by adding 6 M urea to standard 13.5% SDSpolyacrylamide gels as described previously (Kirisako et al. 2000) .
Western blot analysis
Immunofluorescence analysis
Specific proteins were detected in mammalian cells and mouse tissues using immunofluorescence analysis as previously described (Nam et al. 2014 ).
Screening in a zebrafish system
All animal experiments were carried out in accordance with the guidelines in the NIH Guide for the Care and Use of Laboratory Animals. The experiments were approved by an institutional review board. (Kucenas et al. 2008) and Tg(huC:egfp) (Park et al. 2000b ) zebrafish of either sex were used for this study. To block pigmentation in zebrafish, 0.003% (w/v) 1-phenyl-2-thiourea (PTU) was added to the embryo medium at 24 hr post fertilization. Plasmid construction -To produce the cmv:map2k5-egfp and hsp70:map2k5-mCherry constructs, zebrafish map2k5 (GenBank Accession No. EF433292) was amplified by PCR using primers containing attB1 and attB2 sites (Supplemental Methods). The PCR product containing the attB sites was cloned into a middle-entry vector using the BP reaction of the Gateway system (Invitrogen). A 5′ entry clone containing a fragment of the cytomegalovirus (cmv) promoter or zebrafish heat shock protein 70 (hsp70) promoter and a 3′ entry clone containing egfp or mCherry were kindly provided by Dr.
Zebrafish lines -Tg(olig2:dsred2)
Morpholino and RNA injection -
Chien (University of Utah, Salt Lake City, UT) (Kwan et al. 2007 ). The Gateway LR reaction was performed using LR Clonase II with the entry clones, according to the manufacturer's recommendations (Invitrogen). Cell dissociation and FACS were performed as previously described using a FACSAria II (Becton Dickinson). Isolated cells were subsequently homogenized in TRIzol solution (Invitrogen) for the purification of total RNA. cDNA was synthesized using an ImProm-II reverse transcription system (Promega), and the specific oligonucleotide primers were used for RT-PCR.
FACS and RT-PCR -
Whole-mount in situ hybridization -Whole-mount in situ RNA hybridization was performed with sense and antisense RNA probes for zebrafish map2k5 as described previously (Hauptmann and Gerster 2000) . Photos were taken using a differential interference contrast microscope (Axioskop; Zeiss).
Image analysis -For high-magnification in vivo imaging, embryos were anesthetized with 0.03% tricaine (Sigma-Aldrich) and mounted in 0.8% low-melting agarose (SeaPlaque Agarose; Lonza) on glass-bottomed 35-mm dishes (MatTek). Fluorescence images were collected using a LSM510 laser scanning confocal microscope (Zeiss). To 1 test the ability of MAP2K5 MO to knock-down map2k5 expression, one-cell stage zebrafish embryos were injected with control MO or MAP2K5 MO (5 ng) together with hsp70:map2k5:mcherry DNA and then heat-shocked at 24 hpf by incubating them at 39°C for 30 min. After heat shock induction, fluorescence images were collected, and fluorescence intensity was measured by NIS-Elements and ROI statistics software (Nikon).
Statistical analysis
All data are presented as the mean ± S.D. from three or more independent experiments, unless otherwise stated. Different treatments were compared with Student's t-test, oneway ANOVA with Dunnett's multiple comparisons test, or chi-square tests using the SPSS software (version 18.0; SPSS Inc., Chicago, IL). Differences with a p-value less than 0.05 were considered statistically significant.
Data access
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